Kemin’s FloraGLO Legacy Continues with New Blue Light Protection Patent

636040850652417747eyehealth.jpg

14 Jul 2016 --- The United States Patent and Trademark Office has issued Kemin Industries a patent for the role of its products in protecting individuals with three common ocular disorders from blue light or light-induced damage.

The royalty-free license for these products (FloraGLO Lutein and ZeaONE Zeaxanthin, distributed by DSM as OPTISHARP Natural) will provide a ‘huge market opportunity.’
 
Kemin’s patent (US Patent No. 9,226,940 B2) allows vitamin and dietary supplement manufacturers using FloraGLO and/or ZeaONE to position their products for blue light protection. The patent specifically covers products containing ocular antioxidants including lutein and zeaxanthin employed to protect the eye from light-induced damage, particularly the damage caused by the blue wavelengths of light.
 
The patent targets individuals with presbyopia, hyperopia or astigmatism. In these three conditions, blue wavelengths of light are focused directly onto the macula, creating a higher risk for ocular damage.
 
Blue light impacts the majority of adults ages 45 and older who have presbyopia, commonly known as age-related farsightedness.
 
“Because of the widespread prevalence of presbyopia, this patent opens the door for FloraGLO and OPTISHARP Natural customers to make blue light eye protection claims when targeting consumers 45 years and older,” said Dr. Richard Roberts, Patent Inventor and Principal Manager of Scientific Affairs and Technical Services for the Human Nutrition and Health division of Kemin.
 
Nearly every source of light—whether natural or artificial—emits harmful blue wavelengths of light.
The growing prevalence of digital devices like computers, tablets and smartphones is exposing individuals to more blue light than ever before.
 
Over half of Americans use digital devices more than five hours a day and 70% use two or more devices at the same time.
 
In addition to blue light from digital devices, the use of the light emitting diode (LED) in indoor lighting is another growing source of blue light exposure. LED bulbs contain 35% blue light levels as compared to 3% levels in traditional incandescent bulbs. In North America alone, LED lighting made up a US$4.8 billion market in 2012 and is expected to make up a US$42 billion market by 2019.
 
As blue light levels and sources continue to grow, children are especially vulnerable to the effects. Blue light exposure is especially concerning for infants and young children, as nearly every child is born with hyperopia, commonly known as farsightedness. Because of the condition, they are at a higher risk for blue light and light-induced damage as their eyes develop.
 
“Children are exposed to blue light more than ever before. Believe it or not, greater than half of American children use digital devices two or more hours a day,” said Heather Richardson, Vision Platform Senior Product Manager for the Human Nutrition and Health division of Kemin. “Our patent can help customers address this growing concern and develop blue light protection products for kids.”
 
“We are pleased to be able to offer a royalty-free license of our patent to customers who are interested in marketing blue light protection products to adults 45+ and children ages 0-2,” said Anita Norian, President of the Human Nutrition and Health division of Kemin. “It is clear this will be a huge market opportunity for our customers as the concern of blue light exposure and consumer awareness grows.”

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Nutrition & Health News

calocurb: 100 percent plant-based weight management product launched in US market

25 May 2018 --- New Zealand-based nutrition and e-commerce company calocurb has launched its 100 percent plant-based, non-GMO weight management supplement into the US market. The product is designed to curb cravings and reduce calorie intake by around 20 percent at meal or snack time.

Nutrition & Health News

Microbiome solutions: A key theme at Vitafoods Europe 2018

24 May 2018 --- Research into the microbiome – the aggregated microbial species in our body – is gaining increasing attention and investment. Although the term is often associated with digestive health, the body, in fact, contains multiple microbiome. This is currently spurring on research and innovation in areas as wide-ranging as women’s health, weight management, immunity and skin health. At Vitafoods Europe 2018, NutritionInsight spoke with suppliers about their efforts and innovations in the microbiome space, using pre or probiotics for gut health and beyond.

Nutrition & Health News

Nutrient breakthrough: Scientists show plants can be a dietary source of vitamin B12

24 May 2018 --- Scientists at the University of Kent have made a significant discovery about how the vitamin B12 content of some plants can be improved to make vegetarian and vegan diets more complete. Vitamin B12 (known as cobalamin) is an essential dietary component but vegans and vegetarians are more prone to B12 deficiency as plants neither make nor require this nutrient.

Nutrition & Health News

UK sugar reduction efforts fail to reach initial target, industry urged to step up or face tax

23 May 2018 --- The first assessment of the UK government’s sugar reduction program has unveiled failings by industry to reduce sugar in the first year by 5 percent, leading to calls of a sugar tax on sweet treats. The results of the first year have been roundly criticized in the media and described as “hugely disappointing” after Public Health England data revealed that sugar was cut in some categories – sweet spreads and sauces, yogurts and fromage frais and breakfast cereals – while other food groups have fallen short.

Nutrition & Health News

A personal nutrition touch: A key theme at Vitafoods Europe 2018 

22 May 2018 --- Personalized nutrition has become somewhat of a buzzword in the industry over the past year. But despite its popularity, the term “personalized nutrition” is open to many different interpretations, raising the question of how it is actually to be applied in the industry, with experts pointing to the role of wearable devices, mobile apps and forward-looking options such as genetic profiling. At Vitafoods Europe, NutritionInsight spoke with a number of suppliers about their R&D and views on personalized nutrition.    

More Articles
URL : http://www.nutritioninsight.com:80/news/kemins-floraglo-legacy-continues-with-new-blue-light-protection-patent.html